Forbes

Samsung’s Next Cash Cow Could Be This $8B Contract Drugmaker
Forbes
On Thursday, the conglomerate’s contract drug-manufacturing arm will go public on Korea’s main bourse Kospi, and is set to be one of the country’s biggest IPOs ever. Samsung BioLogics said it would sell 16.5 million shares, and after pricing its
At Samsung Electronics, Lee signals more board power in nod to investorsReuters

all 2 news articles »

%d bloggers like this: